EpiVax (United States)

Recent papers from EpiVax (United States)

1. Reduced T cell epitope cross-conservation and immunogenic potential is associated with emergence of a dominant influenza subclade K in 2025Human Vaccines & Immunotherapeutics · 2026
2. Epitope mapping of humoral immunogenicity of orvacabtagene autoleucel shows an IgM response with minimal impact on CAR T cellular kineticsMolecular Therapy Advances · 2026
3. In Silico Hypersensitivity Risk Assessment of Product-Specific Human Contaminant Proteins in Commercial IVIg ProductsSHILAP Revista de lepidopterología · 2026
4. Carbohydrate fatty acid monosulphate ester adjuvant enhances the immunogenicity of influenza antigens via TLR4/2-dependent mechanismsFrontiers in Immunology · 2026
5. Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug ProductsThe AAPS Journal · 2026
6. Immunogenicity risk assessment of peptide-related impurities identified in generic teriparatide productsFrontiers in Immunology · 2025
7. Establishment of Immune Biobank for Vaccine Immunogenicity Prediction Using In Vitro and In Silico Methods Against Porcine Reproductive and Respiratory Syndrome VirusVaccines · 2025
8. Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendationsNucleic Acids Research · 2025
9. A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancerFrontiers in Immunology · 2025
10. T cell epitope content comparison using EpiCC correlates with vaccine efficacy against heterologous porcine reproductive and respiratory syndrome virus type 2 strainsFrontiers in Microbiology · 2025
11. T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccineHuman Vaccines & Immunotherapeutics · 2025
12. Vaccine Confidence During Public Health Challenges and Prior to HPV Vaccine Introduction in MaliVaccines · 2025
13. Regulatory T cell epitope content in human antibodies decreases during maturationFrontiers in Immunology · 2025
14. Immunogenicity of Generic Peptide Impurities: Current Orthogonal ApproachesPharmaceutical Research · 2025
15. Continuity of Care and Lifestyle Intervention Programs for Spanish-Speaking Immigrants Without Health Insurance at a Free Clinic in Rhode IslandPreventing Chronic Disease · 2024
16. Detection of PCV2d in Vaccinated Pigs in Colombia and Prediction of Vaccine T Cell Epitope Coverage against Circulating Strains Using EpiCC AnalysisVaccines · 2024
17. Assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methodsFrontiers in Pharmacology · 2024
18. Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritisFrontiers in Immunology · 2024
19. In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodiesmAbs · 2024
20. Neoadjuvant personalized cancer vaccines: the final frontier?Expert Review of Vaccines · 2024